EMAIL THIS PAGE TO A FRIEND

The international journal of neuropsychopharmacology

Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex.


PMID 24606669

Abstract

The enzymatic activity of histone deacetylases (HDACs) leads to a histone deacetylation-mediated condensed chromatic structure, resulting in transcriptional repression, which has been implicated in the modifications of neural circuits and behaviors. Repeated treatment with electroconvulsive seizure (ECS) induces changes in histone acetylation, expression of various genes, and intrabrain cellular changes, including neurogenesis. In this study, we examined the effects of repeated ECS on the expression of class I HDACs and related changes in histone modifications and gene expression in the rat frontal cortex. Ten days of repeated ECS treatments (E10X) up-regulated HDAC2 expression at the mRNA and protein levels in the rat frontal cortex compared with sham-treated controls; this was evident in the nuclei of neuronal cells in the prefrontal, cingulate, orbital, and insular cortices. Among the known HDAC2 target genes, mRNA expression of N-methyl-d-aspartate (NMDA) receptor signaling-related genes, including early growth response-1 (Egr1), c-Fos, glutamate receptor, ionotropic, N-methyl d-aspartate 2A (Nr2a), Nr2b, neuritin1 (Nrn1), and calcium/calmodulin-dependent protein kinase II alpha (Camk2α), were decreased, and the histone acetylation of H3 and/or H4 proteins was also reduced by E10X. Chromatin immunoprecipitation analysis revealed that HDAC2 occupancy in the promoters of down-regulated genes was increased significantly. Moreover, administration of sodium butyrate, a HDAC inhibitor, during the course of E10X ameliorated the ECS-induced down-regulation of genes in the rat frontal cortex. These findings suggest that induction of HDAC2 by repeated ECS treatment could play an important role in the down-regulation of NMDA receptor signaling-related genes in the rat frontal cortex through histone modification.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2502051
Anti-Hdac1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2701686
Anti-hdac1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701822
Anti-hdac1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
AV38530
Anti-HDAC1 antibody produced in rabbit, IgG fraction of antiserum
SAB2101020
Anti-HDAC1 antibody produced in rabbit, affinity isolated antibody
HPA029693
Anti-HDAC1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300412
Anti-HDAC2 (Ab-394) antibody produced in rabbit, affinity isolated antibody
HPA011727
Anti-HDAC2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV32618
Anti-HDAC2 antibody produced in rabbit, affinity isolated antibody
SAB2104633
Anti-HDAC2 antibody produced in rabbit, affinity isolated antibody
H3284
Anti-Histone Deacetylase 1 (HDAC1) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
H6287 Anti-Histone Deacetylase 1 (HDAC1) antibody, Mouse monoclonal, clone HDAC1-21, purified from hybridoma cell culture
H3159
Anti-Histone Deacetylase 2 (HDAC2) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
H2663
Anti-Histone Deacetylase 2 (HDAC2) antibody, Mouse monoclonal, clone HDAC2-62, purified from hybridoma cell culture
PLA0134
Rabbit anti-HDAC1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
07596
Sodium butyrate, certified reference material, TraceCERT®
C4H7NaO2
19364
Sodium butyrate, ≥99.0% (GC)
C4H7NaO2